Literature DB >> 5018659

Urinary total hydroxyproline: creatinine ratio. Range of normal, and clinical application in British children.

B A Wharton, G Gough, A Williams, S Kitts, C A Pennock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5018659      PMCID： PMC1648009          DOI： 10.1136/adc.47.251.74

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  28 in total

1.  Value of hydroxyproline indices in malnutrition.

Authors:  G R Howells; B A Wharton; R A McCance
Journal:  Lancet       Date:  1967-05-20       Impact factor: 79.321

2.  Clinical significance of urinary hydroxyproline determinations in children.

Authors:  K I Kivirikko; O Laitinen
Journal:  Ann Paediatr Fenn       Date:  1965

3.  Hydroxyproline creatinine ratio as an index of nutritional status and rate of growth.

Authors:  R G Whitehead
Journal:  Lancet       Date:  1965-09-18       Impact factor: 79.321

4.  Urinary hydroxyproline and calcium metabolism in patients with cancer.

Authors:  G Bonadonna; M J Merlino; W P Myers; M Sonenberg
Journal:  N Engl J Med       Date:  1966-08-11       Impact factor: 91.245

5.  The significance of urinary hydroxyproline peptide excretion.

Authors:  M Ziff
Journal:  Proc R Soc Med       Date:  1966-01

6.  Urinary excretion of endogenous hydroxyproline by normal male infants.

Authors:  M K Younoszai; D W Andersen; L J Filer; S J Fomon
Journal:  Pediatr Res       Date:  1967-07       Impact factor: 3.756

7.  Biochemical tests in differential diagnosis of protein and calorie deficiencies.

Authors:  R G Whitehead
Journal:  Arch Dis Child       Date:  1967-10       Impact factor: 3.791

8.  Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II.

Authors:  J M Tanner; R H Whitehouse; M Takaishi
Journal:  Arch Dis Child       Date:  1966-12       Impact factor: 3.791

9.  Biochemical abnormalities in Ehlers-Danlos syndrome.

Authors:  B Straus; N Tejaratchi
Journal:  Arch Intern Med       Date:  1966-11

10.  Hydroxyproline excretion in malignant neoplastic disease.

Authors:  H F Hosley; E G Taft; K B Olson; S Gates; R T Beebe
Journal:  Arch Intern Med       Date:  1966-12
View more
  10 in total

1.  Total hydroxyproline in urine of 4 to 6 year-old children--an investigation on its relationship to growth and nutrition.

Authors:  H Stolley; E Zeh; W Droese
Journal:  Eur J Pediatr       Date:  1977-06-01       Impact factor: 3.183

2.  Parathyroid hormone and calcitonin levels in vitamin D deficient rickets.

Authors:  G Zamboni; M Cecchettin; A Albertini; A Andreoli; G Zoppi
Journal:  Eur J Pediatr       Date:  1979-02-08       Impact factor: 3.183

3.  Hydroxyproline excretion in infantile gastroenteritis.

Authors:  R H Begent; H P Lambert
Journal:  J Clin Pathol       Date:  1977-07       Impact factor: 3.411

4.  Urinary hydroxyproline in children with growth hormone deficiency. Clinical value in diagnosis and prognosis.

Authors:  B A Wharton; G Brown; P H Raynor; G Howells; C A Pennock
Journal:  Arch Dis Child       Date:  1974-02       Impact factor: 3.791

5.  Hydroxyproline excretion in various forms of growth failure.

Authors:  W M Teller; U Genscher; H Burkhardt; K Rommel
Journal:  Arch Dis Child       Date:  1973-02       Impact factor: 3.791

6.  Relation of urinary total hydroxyproline: Creatinine ratio to height velocity in children with retarded growth.

Authors:  S Edwards; M Martog; C A Pennock; J Apley
Journal:  Arch Dis Child       Date:  1976-02       Impact factor: 3.791

7.  Study of the cell biology and biochemistry of cherubism.

Authors:  J Southgate; U Sarma; J V Townend; J Barron; A M Flanagan
Journal:  J Clin Pathol       Date:  1998-11       Impact factor: 3.411

8.  Role of common biochemical markers for the assessment of fracture union.

Authors:  M Mukhopadhyay; R Sinha; M Pal; S Bhattacharyya; A Dan; M M Roy
Journal:  Indian J Clin Biochem       Date:  2011-06-08

9.  Serum levels of aminoterminal type III procollagen peptide in normal subjects and hepatic fibrosis.

Authors:  H Nakano; H Nakabayashi; Y Okamoto; T Kawasaki; S Seko; Y Fukuda
Journal:  Gastroenterol Jpn       Date:  1985-12

10.  Impaired pyridinoline cross-link formation in patients with osteogenesis imperfecta.

Authors:  Kosei Hasegawa; Kyoko Kataoka; Masaru Inoue; Yoshiki Seino; Tsuneo Morishima; Hiroyuki Tanaka
Journal:  J Bone Miner Metab       Date:  2008-07-04       Impact factor: 2.626
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.